Imalumab
Imalumab (BAX69) is a recombinant, human IgG1 monoclonal antibody that targets macrophage inhibitory factor (MIF) . Imalumab can be used for the research of ovarian carcinoma, recurrent malignant ascites and cancer[1].
Product Specifications
CAS Number
[1430205-07-4]
Product Name Alternative
BAX69; Anti-Human MIF Recombinant Antibody
UNSPSC
12352203
Target
Macrophage migration inhibitory factor (MIF)
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/imalumab.html
Purity
98.37
Solubility
10 mM in DMSO
Smiles
[Imalumab]
Molecular Weight
(144.52 kDa)
References & Citations
[1]Bax HJ, et al. Therapeutic targets and new directions for antibodies developed for ovarian cancer. MAbs. 2016 Nov/Dec;8 (8) :1437-1455.|[2]Rossmueller G, et al., Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic. Mol Cancer Ther. 2023 May 4;22 (5) :555-569.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6472394-01 0.2 mL
DGKB, CT (Diacylglycerol Kinase beta, Diglyceride Kinase beta, DGK-beta, DAG Kinase beta, 90kD Diacylglycerol Kinase, DAGK2, KIAA0718) (AP)
Ask
View Details 
MBS6472394-02 5x 0.2 mL
DGKB, CT (Diacylglycerol Kinase beta, Diglyceride Kinase beta, DGK-beta, DAG Kinase beta, 90kD Diacylglycerol Kinase, DAGK2, KIAA0718) (AP)
Ask
View Details 036719-HRP 200 µL
HOXC4, CT (HOXC4, HOX3E, Homeobox protein Hox-C4, Homeobox protein CP19, Homeobox protein Hox-3E) (Azide free) (HRP) discontinued
Ask
View Details MBS1284077-01 0.02 mg (E-Coli)
Recombinant Ginglymostoma cirratum V (D)J recombination-activating protein 1 (rag1)
Ask
View Details